drugset / Trial / NCT00547014
First Safety Study in Humans of a Single Dose of CPG 52364
RandomizedParallel-groupQuadruple-blind
Summary
Determine the safety and tolerability of the study drug, CPG 52364, when given as liquid or capsule. Another purpose is to determine how the drug enters and leaves the blood stream and body tissues over time.
Timeline
- Start
- 2007-09
- Primary completion
- —
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 52364 | Unknown | 1 mg | Oral |
| Subject | 52364 | Unknown | 3 mg | Oral |
| Subject | 52364 | Unknown | 10 mg | Oral |
| Subject | 52364 | Unknown | 30 mg | Oral |
| Subject | 52364 | Unknown | 100 mg | Oral |
Indications
No indication recorded.